Literature DB >> 10414566

Direct and combined revascularization in pediatric moyamoya disease.

A J Golby1, M P Marks, R C Thompson, G K Steinberg.   

Abstract

OBJECTIVE: Surgical revascularization of moyamoya disease can improve neurological outcomes, compared with the natural history of the disease or the results of medical treatment. Controversy exists regarding whether direct or indirect revascularization yields better outcomes. This study involves a single-center experience with direct anastomosis and is the first North American series using direct revascularization for pediatric patients with moyamoya disease.
METHODS: Twelve patients (age range, 5-17 yr; mean age, 10.2 yr) underwent direct revascularization of 21 hemispheres. Two patients had experienced failure of previous indirect revascularization procedures, with continued clinical deterioration. Superficial temporal artery-middle cerebral artery anastomosis was performed in 19 hemispheres (with concurrent encephaloduroarteriosynangiosis in 6). Middle meningeal artery-middle cerebral artery anastomosis and omental transposition were each performed in one hemisphere. Follow-up periods ranged from 12 to 65 months (mean, 35 mo), and monitoring included neurological examinations, angiography, magnetic resonance imaging, and cerebral blood flow studies.
RESULTS: The neurological conditions of all patients were stable or improved after surgery. None of the patients developed new strokes, and no new ischemic lesions were seen in magnetic resonance imaging scans. All grafts evaluated by follow-up angiography were patent. Postoperative cerebral blood flow studies showed significantly improved blood flow (54.4 versus 42.5 ml/100 g/min; P = 0.017, n = 4) and hemodynamic reserve (70.3 versus 43.9 ml/100 g/min; P = 0.009, n = 4), compared with preoperative studies.
CONCLUSION: Surgical revascularization by direct anastomosis in pediatric patients is technically feasible, is well tolerated, and can improve the progressive natural history, the angiographic appearance, and the cerebral blood flow abnormalities associated with the disease. Direct revascularization has the advantage of providing immediate and high-flow revascularization and is particularly useful for patients who have experienced failure of previous indirect revascularization procedures.

Entities:  

Mesh:

Year:  1999        PMID: 10414566     DOI: 10.1097/00006123-199907000-00013

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  Revascularization of the posterior circulation.

Authors:  Bert A Coert; Steven D Chang; Michael P Marks; Gary K Steinberg
Journal:  Skull Base       Date:  2005-02

2.  Transzygomatic-Subtemporal Approach for Middle Meningeal-to-P2 Segment of the Posterior Cerebral Artery Bypass: An Anatomical and Technical Study.

Authors:  Mehmet Erkan Ustun; Mustafa Buyukmumcu; Cagatay Han Ulku; Onder Guney; Ahmet Salbacak
Journal:  Skull Base       Date:  2006-02

3.  Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease.

Authors:  Fumiaki Kanamori; Yoshio Araki; Kinya Yokoyama; Kenji Uda; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Sho Okamoto; Atsushi Natsume
Journal:  Acta Neurochir (Wien)       Date:  2021-01-06       Impact factor: 2.216

Review 4.  Cerebral angiopathies as a cause of ischemic stroke in children: differential diagnosis and treatment options.

Authors:  Hans-Jakob Steiger; Daniel Hänggi; Birgit Assmann; Bernd Turowski
Journal:  Dtsch Arztebl Int       Date:  2010-12-03       Impact factor: 5.594

Review 5.  Moyamoya disease in children.

Authors:  David M Ibrahimi; Rafael J Tamargo; Edward S Ahn
Journal:  Childs Nerv Syst       Date:  2010-07-04       Impact factor: 1.475

6.  Angiographic results of indirect and combined bypass surgery for adult moyamoya disease.

Authors:  In Jae Choi; Sung Jin Cho; Jae Chil Chang; Sukh Que Park; Hyung Ki Park
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28

7.  Clinical features, prothrombotic risk factors, and long-term follow-up of eight pediatric Moyamoya patients.

Authors:  Burak Tatlı; Barış Ekici; Altay Sencer; Serra Sencer; Kubilay Aydın; Nur Aydınlı; Mine Calışkan; Meral Ozmen; Talat Kırış
Journal:  J Clin Neurol       Date:  2012-06-29       Impact factor: 3.077

8.  Pediatric Moyamoya disease.

Authors:  Mohamed Nagiub; Iqbal Allarakhia
Journal:  Am J Case Rep       Date:  2013-05-03

9.  Thirteen-year Experience of 44 Patients with Adult Hemorrhagic Moyamoya Disease from a Single Institution: Clinical Analysis by Management Modality.

Authors:  Won-Seo Choi; Sang-Bok Lee; Dal-Soo Kim; Pil-Woo Huh; Do-Sung Yoo; Tae-Gyu Lee; Kyoung-Suok Cho
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2013-09-30

10.  Case Report: A case report of Moyamoya disease in a 36 year old African American woman.

Authors:  Rohit Kumar Gudepu; Mohtashim A Qureshi; Ihtesham A Qureshi; Lakshman Rao
Journal:  F1000Res       Date:  2014-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.